CV THERAPEUTICS INC
S-3, EX-23.1, 2000-06-02
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: CV THERAPEUTICS INC, S-3, EX-12.1, 2000-06-02
Next: CV THERAPEUTICS INC, S-3, EX-25.1, 2000-06-02




<PAGE>




                                                                    EXHIBIT 23.1

               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS

We consent to the reference to our firm under the caption "Experts" in the
Registration Statement (Form S-3) and related prospectus of CV Therapeutics,
Inc. for the registration of $196,250,000 of 4 3/4% convertible subordinated
notes due March 7, 2000 and 3,074,091 shares of common stock issuable upon
conversion of the notes and to the incorporation by reference therein of our
report dated March 2, 2000, with respect to the consolidated financial
statements of CV Therapeutics, Inc. included in its Annual Report (Form 10-K)
for the year ended December 31, 1999, filed with the Securities and Exchange
Commission.

                                      /s/ ERNST & YOUNG LLP

Palo Alto, California
June 1, 2000


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission